The MACH Omics Strategic Advisory Group (SAG) provided advice, oversight and strategic direction regarding the establishment of the MACH Omics network. This group will now transition to focus on omics to diagnostics with the aim of advancing translation of omics analyses of patient samples into diagnostics by focusing on shareable bioinformatics outputs suitable for incorporation into the Electronic Medical Record.
-
Understanding how immune pressure shapes immune escape mechanisms in non-small cell lung cancer
Read more of the Understanding how immune pressure shapes immune escape mechanisms in non-small cell lung cancer -
ID-Predict (Tuberculosis): Predicting recent Tuberculosis infection and future disease risk in Victorian TB contacts
Read more of the ID-Predict (Tuberculosis): Predicting recent Tuberculosis infection and future disease risk in Victorian TB contacts -
Multi-Omics in Diagnosis and Research of Inherited Rare Diseases
Read more of the Multi-Omics in Diagnosis and Research of Inherited Rare Diseases
MACH Multi-Omics in Action Webinar – 2022
This webinar showcased an exciting multi-omic and multi-institutional approach to addressing rare disease, cancer and infectious disease from leading MACH partner researchers. Hosted by the MACH Omics group, the seminar also provided an overview of multi-omic activity including the MACH Omics Resource Directory.
Presenters: Associate Professor Marie-Liesse Asselin-Labat (WEHI), Associate Professor Sarah Dunstan (Doherty Institute), Professor David Thorburn (MCRI). Chaired by Associate Professor Kaylene Simpson.
-
Bringing Melbourne’s omics experts together
Read more of the Bringing Melbourne’s omics experts together